Publications by authors named "K Lacombe"

Claim this Profile
I
Impact on weight of a Doravirine switch in people living with HIV.
Nina Garofoli, Philippe Flandre, Jean-Paul Vincensini, Quentin Richier, Priscille Couture, Karine Lacombe

HIV Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is migrant status a bacterial sexually transmitted infection risk factor? Prevalence of bacterial sexually transmitted infections in a free-clinic population in France: a monocentric cross-sectional retrospective study.
Armelle Ruck, Maria-Bernarda Requena, Marion Bonneton, Thibault Chiarabini, Karine Lacombe

Int J Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, pharmacokinetics, immunogenicity, and serum neutralizing activity of AZD7442 (tixagevimab-cilgavimab) in hospitalized COVID-19 patients: long-term results from the DisCoVeRy trial.
Clément R Massonnaud, Nathan Peiffer-Smadja, Pascal Poignard, Simon Jamard, François Goehringer, Karine Lacombe

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study.
Romain Palich, Jade Ghosn, Karine Lacombe, Christia Palacios, Pierre Delobel

J Antimicrob Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025.
Caroline Kikawa, John Huddleston, Andrea N Loes, Sam A Turner, Jover Lee, Kirsten Lacombe

Virus Evol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis